Oxidative Stress in Women Treated With Atosiban for Impending Preterm Birth
Status:
Completed
Trial end date:
2018-12-30
Target enrollment:
Participant gender:
Summary
Oxidative stress is recognized as a important factor in the pathogenesis premature birth.
Preterm birth is defined as delivery before 37 completed weeks of gestation and it is the
leading cause of neonatal morbidity and mortality. The investigators conducted this analysis
to investigate the safety of administration of Atosiban - a reversible, competitive
antagonist of the oxytocin receptor in the treatment of preterm labor and its impact on the
level of oxidative stress after 48 hours of tocolytic treatment.
Phase:
N/A
Details
Lead Sponsor:
Polish Mother Memorial Hospital Research Institute